» Articles » PMID: 6163629

Synthesis and Biological Properties of Enzyme-resistant Analogues of Substance P

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1981 Feb 1
PMID 6163629
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Six analogues of substance P were synthesized with the aim of developing a metabolically stable peptide that would retain the biological activity of substance P. A recently isolated and characterized substance-P-degrading enzyme from human brain with a high specificity for substance P described in the preceding paper in this journal was used as a model for the enzymatic inactivation of substance P. The synthetic analogues were designed to protect the peptide bonds on the carboxyl side of residues 6, 7 and 8 of substance P, which represent the sites of cleavage by substance-P-degrading enzyme. To test for increased enzymatic resistance, the analogues were incubated with the enzyme, the digests were separated on a high-performance liquid chromatography reverse-phase column and the peptide fragments were collected and identified by amino acid analysis. Of the analogues described, an heptapeptide analogue of residues 5-11, less than Glu-Gln-Phe-MePhe-MeGly-Leu-MetNH2, showed almost complete resistance both towards substance-P-degrading enzyme and to degradation on exposure to rat hypothalamic slices. This analogue was about a third as potent as substance P in competing for binding to receptor sites for this peptide in rat brain membranes and a tenth as potent in eliciting contractions of the guinea pig ileum. The peptides were synthesized using the solid-phase technique with polydimethylacrylamide as a solid support and the coupling was achieved with pre-formed symmetrical anhydrides in dimethylacetamide. Fluorenylmethyloxycarbonyl was used as an alpha-amino protecting group in conjunction with t-butyloxycarbonyl as an epsilon-amino protecting group. Ammoniolytic cleavage from the resin was followed by stepwise elution from an SP-Sephadex column, deprotection with trifluoroacetic acid and chromatography on a Bio-Rex 70 ion-exchanger. The peptides were finally purified on a semi-preparative reverse-phase column.

Citing Articles

Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin.

DAccolti M, Bellotti D, Dzien E, Leonetti C, Leveraro S, Albanese V Sci Rep. 2023; 13(1):18228.

PMID: 37880318 PMC: 10600247. DOI: 10.1038/s41598-023-45437-0.


Targeting Peptides: The New Generation of Targeted Drug Delivery Systems.

Todaro B, Ottalagana E, Luin S, Santi M Pharmaceutics. 2023; 15(6).

PMID: 37376097 PMC: 10300729. DOI: 10.3390/pharmaceutics15061648.


Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides.

Bellotti D, Remelli M Molecules. 2022; 27(14).

PMID: 35889455 PMC: 9317528. DOI: 10.3390/molecules27144584.


Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi, Met(O)]-Substance P for Future Clinical Application: First Experiences.

Suthiram J, Ebenhan T, Marjanovic-Painter B, Sathekge M, Zeevaart J Pharmaceutics. 2021; 13(9).

PMID: 34575402 PMC: 8472077. DOI: 10.3390/pharmaceutics13091326.


The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.

Majkowska-Pilip A, Halik P, Gniazdowska E Pharmaceutics. 2019; 11(9).

PMID: 31480582 PMC: 6781293. DOI: 10.3390/pharmaceutics11090443.